Rivastigmine

Chemical formula: C₁₄H₂₂N₂O₂  Molecular mass: 250.337 g/mol  PubChem compound: 77991

Active ingredient description

Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones. Thus, rivastigmine may have an ameliorative effect on cholinergic-mediated cognitive deficits in dementia associated with Alzheimer’s disease and Parkinson’s disease.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
N06DA03 Rivastigmine N Nervous system → N06 Psychoanaleptics → N06D Anti-dementia drugs → N06DA Anticholinesterases
Discover more medicines within N06DA03

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
EXELON Transdermal patch European Medicines Agency (EU) MPI, EU: SmPC
EXELON Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 123441-03-2
DrugBank Drug: DB00989
KEGG Drug: D03822
PubChem Compound: 77991
RxNorm Ingredient: 183379
SNOMED-CT Concept: 395868008
Rivastigmine (substance)
UNII Identifier: PKI06M3IW0
RIVASTIGMINE

Medicines

Rivastigmine is an active ingredient of these brands:

United States (US)

  • EXELON as Rivastigmine hydrogen tartrate

Australia (AU)

  • EXELON as Rivastigmine hydrogen tartrate

Austria (AT)

Brazil (BR)

  • EXELON as Rivastigmine hydrogen tartrate
  • RIVASTELON as Rivastigmine hydrogen tartrate
  • TIGMA as RIVASTIGMINE TARTRATE
  • VASTIGMA as RIVASTIGMINE TARTRATE

Canada (CA)

  • EXELON as Rivastigmine hydrogen tartrate

Croatia (HR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

Finland (FI)

France (FR)

  • EXELON as Rivastigmine hydrogen tartrate

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

  • EXELON as Rivastigmine hydrogen tartrate

Italy (IT)

Japan (JP)

Lithuania (LT)

Mexico (MX)

  • EXELON as Rivastigmine hydrogen tartrate

Netherlands (NL)

New Zealand (NZ)

  • EXELON as Rivastigmine hydrogen tartrate

Poland (PL)

Romania (RO)

Singapore (SG)

  • EXELON as Rivastigmine hydrogen tartrate

South Africa (ZA)

  • EXELON as Rivastigmine hydrogen tartrate
  • KYRIZ as RIVASTIGMINE TARTRATE

Spain (ES)

Tunisia (TN)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.